Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BCIC
4876
BCP Investment Corp
BCIC
$85.3M
| $156K | ﹤0.01% |
+1,735
| New | +$165K |
2013 Q3
0 quarters
|
|
|
CMD
4877
CALL
DELISTED
Cantel Medical Corporation
CMD
| $156K | ﹤0.01% |
+4,900
| New | +$130K |
2013 Q3
0 quarters
|
|
4878
Scotiabank
BNS
$111B
| $155K | ﹤0.01% |
2,901
-16,298
| -85% | -$851K |
2013 Q2
1 quarter
|
|
|
CPHD
4879
DELISTED
Cepheid Inc
CPHD
| $155K | ﹤0.01% |
3,972
-5,791
| -59% | -$210K |
2013 Q2
1 quarter
|
|
4880
PUT
Belden
BDC
$4.39B
| $154K | ﹤0.01% |
2,400
+200
| +9% | +$11.7K |
2013 Q2
1 quarter
|
|
4881
Fuel Tech
FTEK
$51.8M
| $154K | ﹤0.01% |
35,218
-7,493
| -18% | -$29.8K |
2013 Q2
1 quarter
|
|
4882
PUT
NovaGold Resources
NG
$2.87B
| $154K | ﹤0.01% |
66,300
-2,400
| -3% | -$6.27K |
2013 Q2
1 quarter
|
|
4883
PUT
Valley National Bancorp
VLY
$7.08B
| $154K | ﹤0.01% |
15,500
-5,700
| -27% | -$57.6K |
2013 Q2
1 quarter
|
|
|
END
4884
CALL
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
| $154K | ﹤0.01% |
28,700
+13,800
| +93% | +$67.3K |
2013 Q2
1 quarter
|
|
|
LPNT
4885
PUT
DELISTED
LifePoint Health, Inc.
LPNT
| $154K | ﹤0.01% |
3,300
-800
| -20% | -$38.3K |
2013 Q2
1 quarter
|
|
4886
CALL
American Water Works
AWK
$25.9B
| $153K | ﹤0.01% |
3,700
-3,900
| -51% | -$161K |
2013 Q2
1 quarter
|
|
4887
CALL
Semtech
SMTC
$18.2B
| $153K | ﹤0.01% |
5,100
-10,800
| -68% | -$340K |
2013 Q2
1 quarter
|
|
|
ABMD
4888
CALL
DELISTED
Abiomed Inc
ABMD
| $153K | ﹤0.01% |
8,000
-7,100
| -47% | -$162K |
2013 Q2
1 quarter
|
|
|
AVNR
4889
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $153K | ﹤0.01% |
36,100
+25,300
| +234% | +$120K |
2013 Q2
1 quarter
|
|
4890
PUT
eHealth
EHTH
$21.5M
| $152K | ﹤0.01% |
4,700
+4,500
| +2,250% | +$124K |
2013 Q2
1 quarter
|
|
|
FMER
4891
CALL
DELISTED
FIRSTMERIT CORP
FMER
| $152K | ﹤0.01% |
7,000
+5,300
| +312% | +$115K |
2013 Q2
1 quarter
|
|
|
STRI
4892
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
| $152K | ﹤0.01% |
22,724
+239
| +1% | +$1.54K |
2013 Q2
1 quarter
|
|
4893
American Superconductor
AMSC
$1.45B
| $151K | ﹤0.01% |
6,437
+2,890
| +81% | +$73.2K |
2013 Q2
1 quarter
|
|
|
4894
Bank of America Series L
BAC.PRL
$3.67B
| $151K | ﹤0.01% |
+140
| New | +$153K |
2013 Q3
0 quarters
|
|
4895
CALL
Guidewire Software
GWRE
$12.5B
| $151K | ﹤0.01% |
+3,200
| New | +$144K |
2013 Q3
0 quarters
|
|
|
POZN
4896
DELISTED
POZEN INC
POZN
| $151K | ﹤0.01% |
26,343
+19,320
| +275% | +$107K |
2013 Q2
1 quarter
|
|
4897
CALL
Equifax
EFX
$16.4B
| $150K | ﹤0.01% |
2,500
-300
| -11% | -$18.5K |
2013 Q2
1 quarter
|
|
4898
CALL
Helen of Troy
HELE
$623M
| $150K | ﹤0.01% |
3,400
-6,200
| -65% | -$261K |
2013 Q2
1 quarter
|
|
4899
PUT
Kaiser Aluminum
KALU
$2.49B
| $150K | ﹤0.01% |
2,100
+1,600
| +320% | +$108K |
2013 Q2
1 quarter
|
|
4900
PUT
Live Nation Entertainment
LYV
$39.3B
| $150K | ﹤0.01% |
8,100
-700
| -8% | -$11.9K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.